CRISPR Therapeutics is a biotechnology company focused on developing gene-editing therapies using the CRISPR-Cas9 technology. This innovative approach allows scientists to precisely modify DNA, potentially correcting genetic disorders and treating various diseases, including certain types of cancer and inherited conditions. The company aims to create transformative treatments by harnessing the power of gene editing. Their research includes developing therapies for conditions like sickle cell disease and beta-thalassemia, with the goal of improving patient outcomes and advancing the field of genetic medicine.